The Pharmacy Times® Infectious Disease Resource Center is a comprehensive resource for clinical news and expert insights on a group of disorders caused by organisms, such as bacteria, viruses, fungi, or parasites.
January 31st 2023
The FDA approved a new azole antifungal for recurrent vulvovaginal candidiasis.
January 27th 2023
Protect patients by evaluating VIGIV concentration and avoiding tearing of metal flange on vaccine vial.
January 25th 2023
Research showed that 600 hospital beds filled with patients with severe illness would be enough to reimplement (mask mandates to stop the spread of infection.
January 24th 2023
Can the profession afford not to retain expanded job roles for technicians in a post-pandemic era?
January 17th 2023
Vaccination provides an opportunity to prevent and treat herpes simplex virus infection.
Fourteen Percent of Those Who Contracted COVID-19 Face Long-Term Challenges
Providers use "Kitchen Sink Approach" because cure proves elusive, symptomatic treatment is sketchy.
Investigational T-cell Therapy for Viral Infections After Allogeneic Stem Cell Transplant Showed 95% Patient Response
Viral infections can plague patients who have undergone stem cell transplantation.
FDA Grants EUA to Mpox PCR Assay Test
There have been more than 80,000 monkeypox cases reported worldwide.
FDA to Review a Preventative RSV Treatment Developed for Infant Population
The novel antibody will receive expedited review, according to the FDA, and already has market authorization in the European Union.
Commonly Overlooked Adverse Effects in the Community, Clinical Pharmacy Settings
Although pharmacists possess a wealth of knowledge on AEs, it remains a monumental task to recall the clinical significance of every AE, even with the most commonly used medications.
Fungal Biomarkers: Primer for Pharmacists
Biomarkers are commonly used by physicians to assist in the earlier diagnosis of some of the most common fungal diseases.
Immunizing Older Individuals Requires Flexibility, Nuance
When it comes to vaccination efforts, remember that patients 65 years or older are not a homogeneous group.
Enhancing Patient Care and the Scope of Practice for Pharmacists, Student Pharmacists Through Immunizations During the Monkeypox Outbreak
Pharmacists and student pharmacists became the center of responding to the Monkeypox outbreak by providing immunizations to their communities.
Investigators Identify Compound That May Halt Infections, Including Common Cold, COVID-19
Findings from the University of British Columbia’s Life Sciences Institute show a potential path toward antiviral treatments that could be used against many different pathogens.
Monkeypox Vaccine Modeling Study Results Provide Road Map for Vaccination
Investigators model 2 hypothetical cities as interconnected networks with a combined population of 100,000 bisexual, gay, and other men who have sex with men.
GSK Releases Positive Study Results for New First-in-Class Tuberculosis Drug
GSK3036656 demonstrates early bactericidal activity with a low, once-daily oral dose after 14 days of treatment.
Analysis Results Show Reductions in HPV-Related Diseases After Using Merck’s Gardasil
Data from an updated systematic literature review show positive outcomes for both cervical and non-cervical disease in men and women.
Bepirovirsen Shows Positive Results in the Treatment of Chronic Hepatitis B
Bepirovirsen produced sustained clearance of hepatitis B virus and hepatitis B surface antigens.
FDA Grants EUA to Roche's Real Time PCR Test for Monkeypox Virus
cobas MPXV targets 2 different regions of the monkeypox virus genome that are less prone to mutations than other parts of the genome.
Study Highlights Need for Person-Centered HIV Prevention Efforts
Although the number of new HIV infections in the world have declined, there are still regions that are geographically heterogenous that have reported an increase in infection rates.
Expert: Long-term Care Industry Needs Help of Pharmacists to Improve Infection Prevention, Control
A session presenter at the ASCP 2022 Annual Meeting explained how the COVID-19 pandemic significantly magnified the importance of infection prevention and control practices in long-term care.
Help Prevent Spread of Pink Eye
School can spread more than knowledge- some researchers suggest that pink eye is most commonly spread among school students.
Investigators Suggest Conjunctivitis May Transmit Monkeypox
Monkeypox may be transmitted through conjunctivitis, according to a new study.
Letermovir Shows Efficacy Preventing Cytomegalovirus Disease in Adults After Kidney Transplantation
The objective of the trial was to compare letermovir with valganciclovir in preventing CMV disease in adults who received a kidney transplant and who are at high risk for CMV disease.
Pharmacy Focus: Public Health Matters- Celebrating American Pharmacist Month Part 3 with Timothy Gauthier
Staying informed through the right sources and being mindful of antibiotic usage can help health care providers and patients be more prepared for future pandemics.
New PCR Test May Detect COVID-19, 2 Other Respiratory Viruses With Near 100% Efficacy
The TaqMan SARS-CoV-2, Flu A/B, RSV RT-PCR multiplex assay can differentiate between 3 different viral infections (including COVID-19), making it highly cost-effective.
Hepatitis B Infection Risk May Be Higher for Males
Males are more likely to suffer from the sexual dimorphism of hepatitis B infection, suggesting that sex hormones have a role in complication risk.
Monkeypox Treatment and Prevention: Stopping the Latest Outbreak
There is not yet an FDA-approved treatment available for monkeypox, but existing antiviral agents have been found to be effective in vitro and in animal studies.
Monkeypox in Populations Presenting with Neurologic Syndromes Require Diagnosis
Included in the literature review were the known neurologic complications of smallpox, including encephalitis, transverse myelitis, and acute disseminated encephalomyelitis.
Study: 2 or More COVID-19 Vaccine Doses Reduces Most Long COVID Symptoms
Investigators find 8 of 10 of the most common symptoms were reported between 50% and 80% less often among those who received at least 2 Pfizer-BioNTech vaccinations.
Monkeypox Treatment: Unnecessary Complexity Can Lead to Inequity
Predictably, patients in underserved rural, urban communities will face challenges gaining access to approved study sites.
OTC Case Studies: Vitamins and Supplements
How would you handle these patient questions?
Daily Medication Pearl: Meropenem, Vaborbactam (Vabomere)
Meropenem and vaborbactam is indicated for the treatment of complicated urinary tract infections for patients aged 18 years and older.
ASHP Urges HHS to Issue PREP Act Declaration Enabling Pharmacists to Administer Monkeypox Vaccines
The move would help ensure timely access to vaccination following the declaration of monkeypox as a public health emergency.
Survey Finds 19% Americans Fear Getting Monkeypox Yet Know Little About Infection
Results also show that nearly half are not sure whether a vaccine exists, and a large majority know that the disease spreads through close contact.
2 Clarke Drive Cranbury, NJ 08512